发明名称 |
METHOD OF PREDICTING A PREDISPOSITION TO QT PROLONGATION |
摘要 |
The present invention describes an association between genetic polymorphisms in the ABCC2 gene and a predisposition to prolongation of the QT interval, and provides related methods for the prediction of such a predisposition, the administration of QT interval-prolonging compounds to individuals having such a predisposition, and determining whether a compound is capable of inducing QT prolongation. |
申请公布号 |
US2015225794(A1) |
申请公布日期 |
2015.08.13 |
申请号 |
US201514694141 |
申请日期 |
2015.04.23 |
申请人 |
Vanda Pharmaceuticals, Inc. |
发明人 |
Lavedan Christian;Volpi Simona;Licamele Louis |
分类号 |
C12Q1/68;C07D413/04 |
主分类号 |
C12Q1/68 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of administering to an individual a compound capable of prolonging the individual's QT interval, the method comprising:
determining at least a portion of an individual's ABCC2 gene sequence; and in the case that a portion of the individual's ABCC2 gene sequence is associated with an increased risk of QT prolongation, administering to the individual a quantity of the compound less than would be administered to an individual having a ABCC2 gene sequence not associated with an increased risk of QT prolongation. |
地址 |
Washington DC US |